Protalix BioTherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2014
Total Assets: $78.4M
Liabilities Breakdown FY2014
Total Liabilities: $134.0M
Asset Breakdown
Total Assets: $78.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $54.8M | 69.9% |
| Accounts Receivable | $1.9M | 2.4% |
| Inventory | $3.5M | 4.4% |
| Property, Plant & Equipment | $11.3M | 14.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $7.0M | 8.9% |
Liabilities Breakdown
Total Liabilities: $134.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.8M | 5.1% |
| Long-Term Debt | $912.0K | 0.7% |
| Other Liabilities | $126.2M | 94.2% |